Use of Bayesian methodology in clinical trials of drug and biological products [pdf]
https://www.fda.gov/media/190505/download
#HackerNews #BayesianMethodology #ClinicalTrials #DrugDevelopment #BiologicalProducts #FDA
Use of Bayesian methodology in clinical trials of drug and biological products [pdf]
https://www.fda.gov/media/190505/download
#HackerNews #BayesianMethodology #ClinicalTrials #DrugDevelopment #BiologicalProducts #FDA
"NIH funding cuts have affected over 74,000 people enrolled in experiments, a new report says."
https://apnews.com/article/nih-funding-cuts-32b9b7bad01457a5412af26e394e3735
This AP article doesn't link to the primary source in _JAMA Internal Medicine_ or the accompanying editor's note, perhaps because they're both #paywalled. (If that's the reason, it's weak.) Here they are:
* primary source
https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2840939
* editor's note
https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2840943
#ClinicalTrials #DefendResearch #Funding #Medicine #NIH #Trump #TrumpVResearch #USPol #USPolitics
Interministerial report on the importance of communicating the results of #clinicaltrials in France.
The report identifies the main levers for improvement and makes operational recommendations designed to support all stakeholders involved. The aim of these recommendations is to facilitate the effective implementation of the European regulation while also promoting a culture of transparency for the benefit of research, patients and society as a whole.
#openscience
https://www.ouvrirlascience.fr/publication-of-an-interministerial-report-on-the-importance-of-communicating-the-results-of-clinical-trials-in-france/
Publication of an interministerial report on the importance of communicating the results of clinical trials in France https://www.ouvrirlascience.fr/publication-of-an-interministerial-report-on-the-importance-of-communicating-the-results-of-clinical-trials-in-france/ #openscience #clinicaltrials #negativeresults
The Ministry of Higher Education and Research (MESR) publishes the results of the French Open Science Monitor for 2024. This year, for the first time, the monitor introduces the monitoring of the adoption of open science policies by institutions.
https://www.ouvrirlascience.fr/publication-of-the-2024-french-open-science-monitor-increased-sharing-of-research-data-but-less-communication-of-clinical-trial-results/?utm_source=dlvr.it&utm_medium=mastodon
#scholarlypublishing #researchdata #opensource #software #clinicaltrials #politics